Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity-Reference-Cited by-同舟云学术

Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity

Published:2016-10-26 Issue:1 Volume:60 Page:35-38
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Bonifacio Ezio,Mathieu Chantal,Nepom Gerald T.,Ziegler Anette-G.,Anhalt Henry,Haller Michael J.,Harrison Leonard C.,Hebrok Matthias,Kushner Jake A.,Norris Jill M.,Peakman Mark,Powers Alvin C.,Todd John A.,Atkinson Mark A.

Funder

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-016-4144-8.pdf

Reference9 articles.

1. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82

2. Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479

3. Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38:1964–1974

4. Elding Larsson H, Vehik K, Gesualdo P et al (2014) Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 15:118–126

5. Meehan C, Fout B, Ashcraft J, Schatz DA, Haller MJ (2015) Screening for type 1 diabetes risk to reduce DKA is not economically viable. Pediatr Diabetes 16:565–572

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing;Clinical Chemistry and Laboratory Medicine (CCLM);2023-06-23

2. The countdown to type 1 diabetes: when, how and why does the clock start?;Diabetologia;2023-05-26

3. Type 1 Diabetes;Clinical Immunology;2023

4. Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development;Biomolecules;2022-10-16

5. Changes in the Coexpression of Innate Immunity Genes During Persistent Islet Autoimmunity Are Associated With Progression of Islet Autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY);Diabetes;2022-06-20